The Five Myths of Generic Competition
- Details
- Category: Research
The Healthcare and Science business of Thomson Reuters has released the white paper, "The Five Myths of Generic Competition," highlighting what originator pharmaceutical and biotech companies can do to improve their forecasting of the likely timing, source and intensity of competition from generic drugs.
New communication opportunities for providers of medical scientific information
- Details
- Category: Research
Deutsche Zeitschrift für Klinische Forschung (DZKF) portal, developed by Geelen & Geelen Beratung für medizinisch-wissenschaftliche Projekte GmbH, now is available in English. The portal is password protected
and accessible only by medical scientific professionals, it allows to publish and read multimedia-format information and send others the related web link(s).
Three Ways for Pharma Product Sites to Improve Visitor Satisfaction and Retain Consumers
- Details
- Category: Research
Pharmaceutical product sites are an important component of an overall brand strategy and can serve as a brand extender for consumers - providing an engaging brand experience that may not be fully realized in the time and space constraints of traditional media.
U.S. Adults With Diabetes Take Control of Care Through Innovative Use of Digital Resources
- Details
- Category: Research
More than ever, type 1 and type 2 diabetes patients are turning to online channels to research treatment and product information, to seek advice and support from others, and to manage their condition. According to pharmaceutical and healthcare market research company Manhattan Research's Cybercitizen Health™ study, nine out of ten online diabetes patients use the Internet to research health information, and two-thirds use the Internet to access pharmaceutical product information.
Biopharmaceutical Companies Risk Delays in Producing Targeted Treatment Solutions
- Details
- Category: Research
A new survey released by IBM (NYSE: IBM) and Silico Research reveals that if biopharmaceutical - or life-sciences - companies fail to collaborate, they risk costly delays in the production of new medicines, medical devices, diagnostics and support services.
Heart attacks linked with antiretroviral treatment
- Details
- Category: Research
New research has helped to explain why patients being treated with antiretroviral drugs for HIV experience a greater incidence of heart attacks. The research was presented by doctors and researchers from the School of Medicine and Medical Sciences at University College Dublin, the Mater Misericordiae University Hospital in Dublin and the Royal College of Surgeons in Ireland at the Retroviral Conference in Montreal, Canada, on 11 February.
Study highlights tragedy of avoidable adverse drug reactions
- Details
- Category: Research
Following the publication of a study into the frequency of Adverse Drug Reactions, First DataBank has spoken out at the tragedy of these avoidable and sometimes fatal errors. The study by PLos One entitled "Adverse Drug Reactions in Hospital In - Patients: A Prospective Analysis of 3695 Patient-Episodes" was covered this week by the BBC and highlighted that "one in seven hospital patients experience adverse drug reactions, half of which are completely avoidable".
More Pharma News ...
- Key Demographics and Behaviors for Consumers Using Search Engines for Online Health and Pharma Info
- The Future of Mobile Health: Mobile Adoption, mHealth and Mobile Marketing
- Manhattan Research Releases Top Pharma Brand Product Sites by Consumer Satisfaction
- Magnetic Resonance Imaging to Assess the Effect of Therapy
- Taking the Pulse® Asia Gives Insight to How Physicians Use Technology
- Med-ePHV Project Keeping an Eye on Medicine
- Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education